Literature DB >> 18371397

Modified patient stem cells as prelude to autologous treatment of muscular dystrophy.

Kay E Davies1, Miranda D Grounds.   

Abstract

Duchenne muscular dystrophy is a devastating muscle wasting disease for which there is no effective treatment. In this issue of Cell Stem Cell, Benchaouir et al. (2007) demonstrate the delivery of genetically corrected CD133+ patient cells into mice, suggesting a new potential avenue for autologous cell therapy.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 18371397     DOI： 10.1016/j.stem.2007.11.003

Source DB:  PubMed          Journal:  Cell Stem Cell        ISSN： 1875-9777            Impact factor:   24.633


  3 in total

1.  Genome-wide Mechanosensitive MicroRNA (MechanomiR) Screen Uncovers Dysregulation of Their Regulatory Networks in the mdm Mouse Model of Muscular Dystrophy.

Authors:  Junaith S Mohamed; Ameena Hajira; Michael A Lopez; Aladin M Boriek
Journal:  J Biol Chem       Date:  2015-08-13       Impact factor: 5.157

2.  Recellularization of acellular human small intestine using bone marrow stem cells.

Authors:  Pradeep B Patil; Priti B Chougule; Vijay K Kumar; Stefan Almström; Henrik Bäckdahl; Debashish Banerjee; Gustaf Herlenius; Michael Olausson; Suchitra Sumitran-Holgersson
Journal:  Stem Cells Transl Med       Date:  2013-03-13       Impact factor: 6.940

Review 3.  Wasting mechanisms in muscular dystrophy.

Authors:  Jonghyun Shin; Marjan M Tajrishi; Yuji Ogura; Ashok Kumar
Journal:  Int J Biochem Cell Biol       Date:  2013-05-11       Impact factor: 5.085
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.